BioCentury | Jul 3, 2020
Management Tracks

Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more

...CMC and Frank Czworka as SVP, global sales. Machielse was CEO of Vtesse Inc., which Sucampo Pharmaceuticals Inc....
BioCentury | Nov 9, 2018
Clinical News

Mallinckrodt Niemann-Pick disease therapy fails pivotal trial

...the 2-hydroxypropyl-b-cyclodextrin targeting cholesterol and sphingolipid storage through its acquisition of Sucampo Pharmaceuticals Inc. (see "Mallinckrodt Acquiring Sucampo"...
BioCentury | Nov 6, 2018
Clinical News

Mallinckrodt Niemann-Pick disease therapy fails pivotal trial

...the 2-hydroxypropyl-b-cyclodextrin targeting cholesterol and sphingolipid storage through its acquisition of Sucampo Pharmaceuticals Inc. (see "Mallinckrodt Acquiring Sucampo"...
BioCentury | Sep 11, 2018
Company News

Management tracks: Cheng joins Akero, bluebird COO leaving

...hired Jones Bryan as SVP of business development. He was SVP of business development at Sucampo Pharmaceuticals Inc....
BioCentury | Aug 15, 2018
Company News

Management tracks: Karuna, VBI Vaccines

...SVP of regulatory and quality. He was VP, global head of regulatory and quality at Sucampo Pharmaceuticals Inc....
...plc (NYSE:MNK) acquired. Jaime De Leon Collegium Pharmaceutical Inc. Evolus Inc. EyePoint Pharmaceuticals Inc. Imara Inc. InVivo Therapeutics Holdings Corp. Karuna Pharmaceuticals Inc. Sucampo Pharmaceuticals Inc. VBI...
BioCentury | Jul 16, 2018
Company News

Management tracks: Cerecor, Sangamo

...is stepping down. She is succeeded by Joe Miller, who was VP of finance at Sucampo Pharmaceuticals Inc....
...of marketing and investor relations. Calias was VP of global CMC and product development at Sucampo...
BioCentury | Mar 22, 2018
Company News

Management tracks: Novo, Nabriva

...chief commercial officer and John Ilett as general counsel. Meyenburg was chief commercial officer at Sucampo Pharmaceuticals Inc....
BioCentury | Jan 12, 2018
Company News

Mallinckrodt divests hemostasis portfolio for $185M

...ammonia scavenger (see BioCentury, Nov. 30, 2017 ). Mallinckrodt will also acquire rare disease company Sucampo Pharmaceuticals Inc....
BioCentury | Jan 9, 2018
Distillery Therapeutics

Autoimmune disease

...efflux mechanism in postmortem patient tissue samples and induced pluripotent stem (iPS) cell-derived cell cultures. Sucampo Pharmaceuticals Inc....
BioCentury | Jan 6, 2018
Finance

Burgeoning bellwethers

...products with clinical or regulatory milestones expected in 2018. (A) Mallinckrodt plc (NYSE:MNK) is acquiring Sucampo Pharmaceuticals Inc....
...NASDAQ:SBBP) Recorlev levoketoconazole Cushing's syndrome Ph III SONICS data; Ph III LOGICS data 2Q18; 4Q18 Sucampo Pharmaceuticals Inc....
...NYSE:NVS; SIX:NOVN) is acquiring Advanced Accelerator Applications S.A. (NASDAQ:AAAP); (B) Mallinckrodt plc (NYSE:MNK) is acquiring Sucampo Pharmaceuticals Inc....
Items per page:
1 - 10 of 263
BioCentury | Jul 3, 2020
Management Tracks

Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more

...CMC and Frank Czworka as SVP, global sales. Machielse was CEO of Vtesse Inc., which Sucampo Pharmaceuticals Inc....
BioCentury | Nov 9, 2018
Clinical News

Mallinckrodt Niemann-Pick disease therapy fails pivotal trial

...the 2-hydroxypropyl-b-cyclodextrin targeting cholesterol and sphingolipid storage through its acquisition of Sucampo Pharmaceuticals Inc. (see "Mallinckrodt Acquiring Sucampo"...
BioCentury | Nov 6, 2018
Clinical News

Mallinckrodt Niemann-Pick disease therapy fails pivotal trial

...the 2-hydroxypropyl-b-cyclodextrin targeting cholesterol and sphingolipid storage through its acquisition of Sucampo Pharmaceuticals Inc. (see "Mallinckrodt Acquiring Sucampo"...
BioCentury | Sep 11, 2018
Company News

Management tracks: Cheng joins Akero, bluebird COO leaving

...hired Jones Bryan as SVP of business development. He was SVP of business development at Sucampo Pharmaceuticals Inc....
BioCentury | Aug 15, 2018
Company News

Management tracks: Karuna, VBI Vaccines

...SVP of regulatory and quality. He was VP, global head of regulatory and quality at Sucampo Pharmaceuticals Inc....
...plc (NYSE:MNK) acquired. Jaime De Leon Collegium Pharmaceutical Inc. Evolus Inc. EyePoint Pharmaceuticals Inc. Imara Inc. InVivo Therapeutics Holdings Corp. Karuna Pharmaceuticals Inc. Sucampo Pharmaceuticals Inc. VBI...
BioCentury | Jul 16, 2018
Company News

Management tracks: Cerecor, Sangamo

...is stepping down. She is succeeded by Joe Miller, who was VP of finance at Sucampo Pharmaceuticals Inc....
...of marketing and investor relations. Calias was VP of global CMC and product development at Sucampo...
BioCentury | Mar 22, 2018
Company News

Management tracks: Novo, Nabriva

...chief commercial officer and John Ilett as general counsel. Meyenburg was chief commercial officer at Sucampo Pharmaceuticals Inc....
BioCentury | Jan 12, 2018
Company News

Mallinckrodt divests hemostasis portfolio for $185M

...ammonia scavenger (see BioCentury, Nov. 30, 2017 ). Mallinckrodt will also acquire rare disease company Sucampo Pharmaceuticals Inc....
BioCentury | Jan 9, 2018
Distillery Therapeutics

Autoimmune disease

...efflux mechanism in postmortem patient tissue samples and induced pluripotent stem (iPS) cell-derived cell cultures. Sucampo Pharmaceuticals Inc....
BioCentury | Jan 6, 2018
Finance

Burgeoning bellwethers

...products with clinical or regulatory milestones expected in 2018. (A) Mallinckrodt plc (NYSE:MNK) is acquiring Sucampo Pharmaceuticals Inc....
...NASDAQ:SBBP) Recorlev levoketoconazole Cushing's syndrome Ph III SONICS data; Ph III LOGICS data 2Q18; 4Q18 Sucampo Pharmaceuticals Inc....
...NYSE:NVS; SIX:NOVN) is acquiring Advanced Accelerator Applications S.A. (NASDAQ:AAAP); (B) Mallinckrodt plc (NYSE:MNK) is acquiring Sucampo Pharmaceuticals Inc....
Items per page:
1 - 10 of 263